Abstract
Background
Although internal mammary chain (IMC) metastases are an independent predictor of prognosis, collecting IMC sentinel nodes (SN) remains controversial. We sought to determine predictors for IMC nodal positivity and the role positive IMC-SNs have on changing staging and management.
Methods
We reviewed a prospectively collected database (1997–2012) to identify patients who had IMC drainage detected on lymphoscintigraphy and underwent biopsy. Chi square tests and logistic regression models were used to determine trends and factors associated with IMC node positivity.
Results
A total of 122 patients with cTis–T2cN0M0 breast cancer underwent IMC-SN biopsy. Mean age of the cohort was 53 years, and mean tumor size was 2.0 cm. Identification of IMC nodes was successful in 100 % of the cases. There were no complications. Sentinel nodes mapped to the IMC alone in 14 of 122 (11 %) patients. Overall, 26 % of patients were node positive, with 12 of 122 (10 %) patients having a positive IMC-SN. In patients with a positive axilla, IMC-SN was positive in 33 % of patients, whereas in patients with a negative axilla, IMC-SN was positive in 3 % of cases (P < 0.001). The number of positive axillary nodes was the only independent predictor of IMC positivity (1–3 positive axillary nodes odds ratio 16.9, 95 % CI 3.1–91.1; ≥4 positive axillary nodes odds ratio 45.0, 95 % CI 4.0–500.7). IMC-SN positivity led to a more advanced nodal category in all patients and more accurate staging in 4 of 12 (33 %) patients.
Conclusions
IMC-SN biopsy is predictable and safe. Identification of IMC metastases though IMC-SN biopsy has the potential to alter the stage and adjuvant therapy of breast cancer patients.
Similar content being viewed by others
References
Hultborn KA, Larsson LG, Ragnhult I. The lymph drainage from the breast to the axillary and parasternal lymph nodes, studied with the aid of colloidal Au198. Acta Radiol. 1955;43:52–64.
Turner-Warwick RT. The lymphatics of the breast. Br J Surg. 1959;46:574–82.
Blumgart EI, Uren RF, Nielsen PM, Nash MP, Reynolds HM. Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer. Breast Cancer Res Treat. 2011;130:699–705.
Hindie E, Groheux D, Hennequin C, et al. Lymphoscintigraphy can select breast cancer patients for internal mammary chain radiotherapy. Int J Radiat Oncol Biol Phys. 2009;83:1081–8.
Carcoforo P, Basaglia E, Soliani G, et al. Sentinel node biopsy in the evaluation of the internal mammary node chain in patients with breast cancer. Tumori. 2002;88:S5–7.
van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234:79–84.
Heuts EM, van der Ent FW, von Meyenfeldt MF, Voogd AC. Internal mammary lymph drainage and sentinel node biopsy in breast cancer—a study on 1008 patients. Eur J Surg Oncol. 2009;35:252–7.
Estourgie SH, Tanis PJ, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Kroon BB. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol. 2003;10:935–41.
Farrus B, Vidal-Sicart S, Velasco M, et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys. 2004;60:715–21.
Veronesi U, Cascinelli N, Bufalino R, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983;198:681–4.
Sugg SL, Ferguson DJ, Posner MC, Heimann R. Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol. 2000;7:188–92.
Cody HS 3rd, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995;2:32–7.
Cserni G, Szekeres JP. Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg Oncol. 2001;10:25–33.
Morrow M, Foster RS Jr. Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg. 1981;116:748–51.
Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985;202:702–7.
Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I, Mizukami Y. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer. 1991;68:1918–25.
Noguchi M, Koyasaki N, Ohta N, et al. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer. Arch Surg. 1993;128:242–6.
American Joint Committee on Cancer. Breast. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 347–76.
Galimberti V, Veronesi P, Arnone P, et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol. 2002;9:924–8.
Avisar E, Molina MA, Scarlata M, Moffat FL. Internal mammary sentinel node biopsy for breast cancer. Am J Surg. 2008;196:490–4.
Postma EL, van Wieringen S, Hobbelink MG, et al. Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat. 2012;134:735–41.
Huang O, Wang L, Shen K, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat. 2008;107:379–87.
Noguchi M, Ohta N, Thomas M, Kitagawa H, Miyazaki I. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients. J Surg Oncol. 1993;52:26–30.
Madsen E, Gobardhan P, Bongers V, et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol. 2007;14:1486–92.
Noguchi M, Taniya T, Koyasaki N, Miyazaki I. A multivariate analysis of en bloc extended radical mastectomy versus conventional radical mastectomy in operable breast cancer. Int Surg. 1992;77:48–54.
Cranenbroek S, van der Sangen MJ, Kuijt GP, Voogd AC. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat. 2005;89:271–5.
Fowble B, Solin LJ, Schultz DJ, Goodman RL. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys. 1989;17:703–10.
Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1991;9:988–96.
Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer. 1977;39(6 Suppl):2827–39.
Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009;27:2946–53.
Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–32.
Arriagada R, Le MG. Adjuvant radiotherapy in breast cancer—the treatment of lymph node areas. Acta Oncol. 2000;39:295–305.
Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management—a systematic review. J Clin Oncol. 2008;26:4981–9.
Taghian A, Jagsi R, Makris A, et al. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys. 2004;60:706–14.
Veronesi U, Arnone P, Veronesi P, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol. 2008;19:1553–60.
He Q, Zhuang D, Tian J, Zheng L, Fan Z, Li X. Surgical approach to internal mammary sentinel node biopsy. J Invest Surg. 2010;23:321–6.
Acknowledgment
This study was supported in part by the Butz Foundation.
Disclosure
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gnerlich, J.L., Barreto-Andrade, J.C., Czechura, T. et al. Accurate Staging with Internal Mammary Chain Sentinel Node Biopsy for Breast Cancer. Ann Surg Oncol 21, 368–374 (2014). https://doi.org/10.1245/s10434-013-3263-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-013-3263-4